Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Arialys Therapeutics is a pre-clinical stage company that develops auto-antibody focusing on neuroscience.
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.
Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.
TwinStrand Biosciences develops and commercializes the duplex sequencing technology for DNA sequencing.
AltPep provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.
Adaptive Phage Therapeutics provides therapeutic services intended to treat multi-drug resistant pathogenic bacteria.
Bitterroot Bio leverages the power of immunotherapy to develop and deliver novel medicines for cardiovascular disease.
Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.
Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform.
Vesigen Therapeutics is a biotechnology company that develops groundbreaking therapeutic products.
Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.
QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.
Paratus Sciences is dedicated to advancing human health and health security by comprehending the biology of bats.
IgGenix is a biotechnology company.
Melonfrost is a biotechnology company based in Brooklyn, New York.
Expansion Therapeutics is a biotechnology company focusing on developing transformative oral medicines for severe RNA-mediated diseases.
Developer of a pharmaceutical platform and drugs created for the treatment of the central nervous system.
Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.
Haystack Oncology enables precision oncology to optimize treatment strategies.
Tavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer.
Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.
Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.
Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.
Alexandria Venture Investments has invested in 184 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Alexandria Venture Investments's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Genetics. The firm invests across 19 different industry categories.
Among tracked funding rounds, Bitterroot Bio received $145.0M in a Series A round. Alexandria Venture Investments's total known invested capital is $8.0B.
Alexandria Venture Investments's average investment size is $43.4M across its portfolio of 184 companies.
Recent Alexandria Venture Investments portfolio additions include Arialys Therapeutics, ROME Therapeutics, Evelo Biosciences, TwinStrand Biosciences, AltPep. These companies were founded in 2020 or later.